Despite the presence of harmonized experimental data on the decreased IGF-1 levels in brain in depression and cognitive impairment, there are discrepancies in the estimation of the peripheral IGF-1 concentrations in patients suffering from MDD. The gene discussed is IGF1; the disease is depressive disorder.